John Bell - Aug 20, 2020 Form 4 Insider Report for Cure Pharmaceutical Holding Corp. (AVRW)

Role
Director
Signature
/s/ John Bell
Stock symbol
AVRW
Transactions as of
Aug 20, 2020
Transactions value $
$0
Form type
4
Date filed
5/27/2021, 07:34 PM
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVRW Common Stock Award $0 +17.6K $0.00 17.6K Aug 20, 2020 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVRW Restricted Stock Unit Award $0 +61.7K $0.00 61.7K Sep 23, 2020 Common Stock 61.7K $0.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock received upon vesting of a restricted stock award. This late filing is due to an inadvertent administrative error and not any error of the reporting person.
F2 The reporting person received restricted stock units under the equity incentive plan. Vesting occurs within a one-year term or until the next annual meeting of shareholders. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. This late filing is due to an inadvertent administrative error and not any error of the reporting person.